| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Nov 24 | KROS Keros Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 67.91 | 110,000 | 7.47 mm | 110,000 |
| 23 Oct 23 | TRML Tourmaline Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 9.46 | 73,211 | 692.58 k | 73,211 |
| 19 Oct 23 | TRML Tourmaline Bio | Common Stock | Grant | Acquire A | No | No | 0 | 56,836 | 0.00 | 56,836 |
| 19 Oct 23 | TRML Tourmaline Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 7.9 | 144,215 | 1.14 mm | 144,215 |
